APA (7th ed.) Citation

T, M., A, B., S, T., CS, K., CP, M., SK, C., & MG, M. (2022). Cannabis Sativa L. Flower and Bud Extracts Inhibited In vitro Cholinesterases and β-Secretase Enzymes Activities: Possible Mechanisms of Cannabis Use in Alzheimer Disease. Endocrine, metabolic & immune disorders drug targets, 22(3), 297. https://doi.org/10.2174/1871530321666210222124349

Chicago Style (17th ed.) Citation

T, Mooko, Bala A, Tripathy S, Kumar CS, Mahadevappa CP, Chaudhary SK, and Matsabisa MG. "Cannabis Sativa L. Flower and Bud Extracts Inhibited In Vitro Cholinesterases and β-Secretase Enzymes Activities: Possible Mechanisms of Cannabis Use in Alzheimer Disease." Endocrine, Metabolic & Immune Disorders Drug Targets 22, no. 3 (2022): 297. https://doi.org/10.2174/1871530321666210222124349.

MLA (9th ed.) Citation

T, Mooko, et al. "Cannabis Sativa L. Flower and Bud Extracts Inhibited In Vitro Cholinesterases and β-Secretase Enzymes Activities: Possible Mechanisms of Cannabis Use in Alzheimer Disease." Endocrine, Metabolic & Immune Disorders Drug Targets, vol. 22, no. 3, 2022, p. 297, https://doi.org/10.2174/1871530321666210222124349.